review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1191/096120300680198935 |
P698 | PubMed publication ID | 10866094 |
P2093 | author name string | A L Metzger | |
D J Wallace | |||
J R Klinenberg | |||
D Hallegua | |||
R Z Rinaldi | |||
P2860 | cites work | Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study. | Q54145043 |
Effects of cyclosporine in severe systemic lupus erythematosus. | Q54395791 | ||
Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study | Q33496027 | ||
Ciclosporin in the treatment of lupus nephritis | Q45350416 | ||
Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center | Q46713957 | ||
Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group | Q46839690 | ||
The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. | Q53955578 | ||
P433 | issue | 4 | |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 241-251 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature | |
P478 | volume | 9 |
Q34250896 | Clinical trials in lupus nephritis |
Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
Q38976307 | Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis |
Q37754815 | Management of systemic lupus erythematosus in Chinese patients |
Q36054868 | Membranous lupus nephritis |
Q37559367 | Membranous lupus nephritis in Chinese children--a case series and review of the literature. |
Q37423758 | Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma |
Q43248383 | Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis |
Q61974567 | Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria |
Q34481499 | Novel approaches in the treatment of lupus nephritis |
Q38542910 | Pharmacokinetic modeling of therapies for systemic lupus erythematosus. |
Q39425964 | Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis |
Q37146440 | Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy |
Q93193261 | Systemic lupus erythematosus: Diagnosis and clinical management |
Q46407226 | Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. |
Q53649024 | Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. |
Q38925320 | The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review |
Q38829637 | The safety of pharmacological treatment options for lupus nephritis |
Q42728756 | Treatment of lupus nephritis |
Q43853399 | Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A. |
Q79370762 | Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine |
Q36575376 | Update on the treatment of lupus nephritis |
Search more.